Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BRISTOL-MYERS SQUIBB COMPANY

(BMY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Bristol Myers Squibb : Morgan Stanley Lifts Price Target on Bristol-Myers Squibb to $71 From $62, Citing 'Strong' Q2 Results; Equal-Weight Rating Kept

07/29/2021 | 07:43am EDT


ę MT Newswires 2021
All news about BRISTOL-MYERS SQUIBB COMPANY
04:53aTcr-2 therapeutics announces clinical trial collaboration agreement with bristol myers ..
AQ
10/25GLOBAL MARKETS LIVE : HSBC, PayPal, Tesla, Daimler, Intel...
10/25TCR2 THERAPEUTICS : Initiates Clinical Trial Partnership With Bristol Myers Squibb to Eval..
MT
10/25Aurinia Pharmaceuticals Shares Rally on Report of Bristol Myers Interest
DJ
10/25BRISTOL MYERS SQUIBB : Announces Earnings Call Time Change; Third Quarter 2021 Earnings Ca..
BU
10/25BRISTOL MYERS SQUIBB : TCR▓ Therapeutics Announces Clinical Trial Collaboration Agreement ..
AQ
10/22BRISTOL-MYERS CVR INVESTORS : December 6, 2021 Filing Deadline in Class Action – Con..
BU
10/22BRISTOL MYERS SQUIBB : Reportedly Approaches Aurinia Pharmaceuticals For Takeover; Aurinia..
MT
10/22AURINIA PHARMACEUTICALS : Bristol-Myers Reportedly Makes Takeover Approach to Aurinia Phar..
MT
10/22Lymphoma Hub maintains its focus on raising the levels of global knowledge of lymphoma ..
AQ
More news
Analyst Recommendations on BRISTOL-MYERS SQUIBB COMPANY
More recommendations
Financials (USD)
Sales 2021 46 329 M - -
Net income 2021 6 492 M - -
Net Debt 2021 28 443 M - -
P/E ratio 2021 20,1x
Yield 2021 3,40%
Capitalization 128 B 128 B -
EV / Sales 2021 3,39x
EV / Sales 2022 3,06x
Nbr of Employees 30 250
Free-Float 76,0%
Chart BRISTOL-MYERS SQUIBB COMPANY
Duration : Period :
Bristol-Myers Squibb Company Technical Analysis Chart | BMY | US1101221083 | MarketScreener
Technical analysis trends BRISTOL-MYERS SQUIBB COMPANY
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 57,81 $
Average target price 74,62 $
Spread / Average Target 29,1%
EPS Revisions
Managers and Directors
Giovanni Caforio Chairman & Chief Executive Officer
David V. Elkins Chief Financial Officer & Executive Vice President
Paul von Autenried Chief Information Officer & Executive VP
Rupert J. Vessey Executive VP-Research & Early Development
Joseph E. Eid Senior VP & Head-Global Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
BRISTOL-MYERS SQUIBB COMPANY-6.80%128 460
JOHNSON & JOHNSON4.26%431 938
ROCHE HOLDING AG15.61%338 364
NOVO NORDISK A/S59.69%243 351
PFIZER, INC.17.25%241 929
ELI LILLY AND COMPANY45.14%222 158